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1. Introduction 
Many factors are involved in the pathogenesis of stress urinary incontinence (SUI) and for 
several decades attempts have been made to design the best device for its treatment. 
Experience and research have led to important breakthroughs, but there is currently no 
100% effective treatment devoid of complications. As treatments have changed, the 
materials and access routes have given way to complications not previously reported that 
have sometimes been fatal.  ObGyns, urologists and urogynecologists that perform surgical 
procedures for urinary incontinence would like to have the best kit and none of the reported 
complications, but in actuality, everyone has such complications. Every surgeon wonders: 
What was the cause of this complication? How will it be resolved? How is it classified? For 
future patients, how can such a complication be prevented? There have been reports of 
erosion and/or extrusion of material in new kits or devices for urinary incontinence in the 
urethra, bladder, vagina and ureter; as well as bleedings during the surgical procedure with 
injury to the pelvic or vaginal vessels, suburethral hematomas, intestinal perforation, 
voiding dysfunction, nerve lesions, bladder perforation, infections and abscesses, de novo 
overactive bladder, pelvic pain, necrotizing fasciitis and even death.   
For decades, different types of materials have been used, such as monofilament or 
multifilament mesh, micropore, macropore, silicone, polyester, polypropylene and gore-tex, 
and none of them is free of complications.  
This chapter is an overview of the complications reported according to the device or kit 
used, the type of mesh, with reference to the classification of complications of the 
International Continence Society (ICS) and the International Urogynecological Association 
(IUGA) and the treatments used to resolve these complications. It is necessary to adequately 
follow the technical procedure, check the correct position of the patient´s legs, know the 
anatomy and receive periodical training.   
2. History  
The first to use synthetic material for a female urethral sling were Williams and Te Linde in 
1962, followed by Ridley in 1966 and Morgan in 1970, using a polypropylene Marlex mesh 
for recurrent stress urinary incontinence. Subsequently, Morgan and colleagues (1985) 
reported at least a 5 year follow-up of patients with a 77.4% success rate. The complications 
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of this procedure include bladder neck obstruction and chronic cystitis. Subsequently, his 
patients had problems of erosion, infection and fistula formation 
Vervigni and Natale (2001) described the three most important components for the use of a 
mesh in urological reconstructive surgery: the pore size, the type of fiber and its inflexibility. 
The pore size and the type of fiber may be used to classify mesh in 4 types: Mesh type 1, 
such as prolene, which is very soft (Ethicon, Endosurgery Inc, Summerville) and Marlex, 
having a long pore (>75μg) and usually made of polypropylene. This pore size allows 
macrophages to cross over and there is growth of fibroblasts (fibroplasias), as well as blood 
vessels (angiogenesis), and collagen deposits; White (1988) reported that because of these 
features, the mesh leads to changes to prevent infections and fibrous connective tissue 
grows around the tissue. Type II mesh such as Gore-tex (WL Gore & Associates Inc; 
Flagstaff, AZ) has a pore size under 10 μg in each one of its three dimensions (micropore). 
Mesh type III, such as Mersilene, is a macropore shaped naturally, but with micropore 
components that often include braided material and one/or multiple filaments. Mesh type 
IV has material with a pore size under a micron, and it is not used as a sling for urinary 
incontinence surgical procedures. (Table 1). Another important property is fiber 
composition: polypropylene mesh is made of monofilament and there are others made of 
multiple filaments which are commonly used. Multiple filament mesh often has a hole less 
than 10 μg wide, allowing small bacteria to infiltrate and proliferate. In theory, this small 
hole does not allow macrophages (16 to 20 μg) or white cells (9 a 15 μg) to pass through to 
kill bacteria, resulting in potential risk of infections. Flexibility or inflexibility of the mesh is 
another important feature. Prolene has a pore size twice as big as Marlex (1500 μg vs. 600 
μg) and is much more flexible. Considering all of these properties, theoretically, prolene 
may have the lowest rate of erosion on the vagina and adjacent organs.   
  
Type Fiber Pore Size 
I Monofilament Macro(>75μm) 
II Multifilament Micro(<75μm) 
III Multifilament Variable 
IV Monofilament Submicro 
Table 1. Classification of Mesh Types 
Ulmsten et al (1996) were the first to use a tension-free polypropylene mesh (TVT) to repair 
female stress urinary incontinence. They used a prolene mesh to support the mid urethra. 
The procedure needs to be performed with cystoscopy. This procedure was designed to 
avoid excessive tension and the kit is adjusted according to a cough test. The authors do not 
report any complication during surgery and they conclude that the procedure has a good 
success rate. This surgical procedure was known worldwide and surgeons started to use it, 
however some time later, complications were reported in publications. Primicero et al (1999) 
used the device in 24 patients, reporting a case of a patient with perforation of the external 
iliac vein and needing surgical repair. Brink (2000) reported a case of intestinal injury. 
Already in the year 2005 Atherton and Stanton reported that the bladder perforation rate 
with this kit has a 4.4% incidence in up to 71% of cases, but these were not the only 
complications. Delorme et al (2204) was the first to use the approach through the obturator 
hole. In this procedure it is not necessary to use cytoscopy. But some time later, urinary tract 
injuries were also documented.  
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Lapitan et al (2009), in their systematic Cochrane review, evaluated the different treatments 
for urinary incontinence: open retropubic vaginal suspension, among others, and the 
tension-free vaginal tape. This review included 46 articles for a total of 4738 women. The 
total cure rate for open retropubic vaginal suspension was 68.9% to 88%. When open 
retropubic vaginal suspension is compared to the tension-free tape in 12 studies, there is no 
difference in the success rate throughout the follow-up time. The available evidence 
according to Lapitan´s report is that there is no high morbidity or complication rate 
difference between these two surgical procedures. 
Several commercial houses have started to change the mesh placement, with different access 
routes, either inside-out or outside-in; with suprapubic or transobturator approach.  
3. Classification  
Haylen et al (2011) in The Standardization and Terminology Committees of the International 
Urogynecological Association (IUGA) and the International Continence Society (ICS) and the 
joint IUGA/ICS working group on Complications Terminology seek to provide a terminology 
and a standardized classification for those complications arising directly from the insertion of 
prostheses and graft in female pelvic floor surgery. A significant increase in the use of an ever 
widening array of prostheses and graft has occurred in female pelvic floor surgery over the 
last 30 years. Terminology involved in the classification (Table 2), Classification of complications 
related directly to the insertion of prosthesis (Table 3) and Grades of pain (Table 4) 
 
TERMS USED DEFINITION 
PROSTHESIS A Fabricated substitute to assist a damaged body part or to 
augment or stabilize a hypoplastic structure 
a. Mesh 
b. Implant 
c. Tape(sling) 
A (prosthetic) network fabric or structure  
A surgically inserted or embedded prosthesis 
A flat strip of synthetic material 
GRAFT Any tissue or organ for transplantation. This term will refer to 
biological materials inserted. 
a. Autologous Grafts 
 
b. Allografts 
c. Xenografts 
From the woman’s own tissues e.g. dura mater, rectus sheath or 
fascia lata 
From post-mortem tissue banks 
From other species e.g. modifies porcine dermis, porcine small 
intestine, bovine pericardium 
COMPLICATION A morbid process or event that occurs during the course of a 
surgery that is not an essential part of that surgery 
CONTRACTION Shrinkage or reduction in size 
PROMINENCE Parts that protrude beyond the surface (e.g. due to wrinkling or 
folding with no epithelial separation) 
SEPARATION Physically disconnected (e.g. vaginal epithelium) 
EXPOSURE A condition of displaying, revealing, exhibiting or making accessible 
e.g. vaginal mesh visualized through separated vaginal epithelium 
EXTRUSION Passage gradually out of a body structure or tissue  
COMPROMISE Bring into danger 
PERFORATION Abnormal opening into a hollow organ or viscus 
DEHISCENCE A bursting opening or gaping along natural or sutured line 
Table 2. Terminology involved in the Classification. 
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  CATEGORY   
GENERAL 
DESCRIPTION 
A 
ASYMPTOMATIC 
B 
SYMPTOMATIC 
C 
INFECTION 
D 
ABSCESS 
(+) 
1 VAGINAL: no epithelial 
separation. Includes 
prominence (e.g. due to 
wrinkling or folding), 
mesh fiber palpation or 
contraction (shrinkage 
1 A : Abnormal 
prosthesis or graft 
finding on clinical 
examination 
1 B: Symptomatic 
e.g. unusual 
discomfort/pain; 
dispareunia 
(either partner); 
bleeding 
1C: Infection 
(suspected or 
actual) 
1D: (+) 
2 VAGINAL: Smaller ≤ 
1cm exposure 
2A : Asymptomatic 2B: Symptomatic 2C: Infection 2D: (+) 
3 VAGINAL: larger >1 cm 
exposure, or any 
extrusion 
3A: Asymptomatic 
1-3Aa if no prosthesis 
or graft related pain 
3B: Symptomatic 
1-3B(b-e) if 
prosthesis or 
graft related pain 
3C: Infection 
1-3C/1-3D (b-e) 
if prosthesis or 
graft related 
pain 
3D: (+) 
4 URINARY TRACT: 
Compromise or 
perforation including 
prosthesis(graft) 
perforation, fistula and 
calculus 
4A: Small intra-
operative defect e.g. 
bladder perforation 
4B: Other lower 
urinary tract 
complication or 
urinary retention 
4C: Ureteric or 
upper urinary 
tract 
complication 
 
5 RECTAL OR BOWEL: 
Compromise or 
perforation including 
prosthesis(graft) 
perforation and fistula 
5A: Small intra-
operative defect 
(rectal or bowel) 
5B: Rectal injury 
or compromise 
5C: Small or 
large bowel 
injury or 
compromise 
5D (+) 
6 SKIN AND/OR 
MUSCULOSKELETAL 
Complications including 
discharge pain lump or 
sinus tract formation 
6A: Asymptomatic, 
abnormal finding or 
clinical examination 
6B: Symptomatic 
e.g. discharge, 
pain or lump 
6C: Infection 
e.g. sinus tract 
formation 
6D (+) 
7 PATIENT: Compromise 
including hematoma or 
systemic compromise 
7A: Bleeding 
complication 
including hematoma 
7B: Major degree 
of resuscitation or 
intensive care 
7C: Mortality* 
*additional 
complication 
*no site 
applicable-S0) 
 
TIME ( CLINICALLY DIAGNOSED) 
T1: Intraoperative to 48 
hours 
T2: 48 hours to 2 
months 
T3: 2 months to 12 
months 
T4: Over 12 months 
SITE 
S1: Vaginal area of 
suture line 
S2: Vaginal: away from 
area of suture line. 
S3: Trocar passage 
Exception: Intra-
abdominal(S5) 
S4: Other skin or 
musculoskeletal site 
Table 3. A Classification of complications related directly to the insertion of prosthesis 
(meshes, implants, tapes) or graft in female pelvic floor surgery. 
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To specify the presence of pain (by the patient only, not the partner) as part or all of the 
abnormal findings and the grade in terms of presence and severity of symptoms 
a  Asymptomatic or no pain 
b  Provoked pain only (during vaginal examination) 
c  Pain during sexual intercourse 
d  Pain during physical activities 
e  Spontaneous pain.  
Table 4. Grades of pain: Sub classification of complication category 
4. Pathophysiology 
Jeffry et al (2001) reported that the bladder lesion rate due to perforation, increased in 
patients who had a prior anti-incontinence surgical procedure, this is due to the retropubic 
scarring process, and they also observed that the bladder perforation site is greater on the 
opposite side of the surgeon’s dominating hand.  
Is a bladder lesion never observed during cystoscopy? Not really. Buchsbaum et al in (2004) 
reported that when they discarded the presence of bladder lesion after a cystoscopy, they 
found fluid leak through the incision or through the trocar path. Therefore, it is important to 
perform an appropriate bladder distension in order to separate the bladder folds and 
discard or confirm this complication appropriately. If necessary, methylene blue or indigo 
carmine can be used.  
What is the anatomical relationship between vascular anatomy and placement of trocars in 
the insertion of a TVT? Muir et al (2003) did an anatomical dissection in cadavers and found 
that the TVT trocar goes through at an average distance of 4.9 cm from the external iliac 
artery and 3.2 cm from the obturator vessels, therefore, when the trocar goes in deviated 
laterally, it can cause an injury to the external iliac artery or vein. An inadequate technique 
when the trocar is inserted can cause severe complications. 
Is the patient’s position as well as position of the legs important to avoid complications? Yes. 
Whiteside et al (2004) reported the anatomy of the neurovascular bundle in relation to the 
obturator fossa when the TOT is placed; the trocar goes through at a 1.1 ± 0.4 cm average 
distance from the medial branch of the obturator vessels and the average distance to the 
obturator nerve is 2.5 ± 0.7 cm. Hubka et al (2010) reported in a study of 14 embalmed 
bodies with poor position of the legs (group 1), 5 fresh frozen bodies with poor leg position 
(group 2) and 5 fresh frozen bodies with the proper leg position (group 3).  After dissection, 
they measured the rami of the obturator nerve; in group 1, the average distance of the 
anterior ramus of the obturator nerve was at 8.4 mm (left) and at 8.9 mm (right). In group 2 
the average was 5 mm (left) and at 8 mm (right) and the posterior ramus of the obturator 
nerve was at 5 mm (left) and 8 mm (right) respectively. In group 3, the average distance of 
the anterior ramus of the obturator nerve was 24mm (left) and 23 mm (right). Therefore, the 
correct position of the patient and of the legs ensures proper placement of the TVT-O. 
Several factors have been proposed for complications with these kits: broad dissection with 
devascularization of the vaginal tissue, estrogen deficiency, excess tension, and presence of 
subclinical or overt infection before surgery, poor placement of the patient’s legs during 
surgery, poor knowledge of the surgical technique to place the kits and smoking.   
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Atis et al (2009) did an assessment in rats to see the reaction produced by the materials of 
the different slings in the bladder through histopathology (TVT, Vypro mesh, intravaginal 
plastic sling: IVS); they studied 30 rats with a similar control group, through laparotomy 
they placed a 0.5 to 1 cm mesh on the anterior bladder wall; after 12 weeks they did a 
hystopathological test of the bladder. They found signs of inflammation, reaction to a 
foreign body, subserous fibrosis, necrosis and different degrees of collagen deposits. The 
Kruskal-Wallis and Posthoc Dunn tests were performed, observing that the inflammatory 
process was greater in the IVS (p= 0.001) group than in the TVT (p= 0.006) group, and Vypro 
(p=0.031); this IVS group also showed greater subserous fibrosis (p=0.0001); reaction to a 
foreign body (p=0.0001) and more collagen deposit (p=0.0001). The bladder showed a 
greater inflammatory response in the IVS group than in the TVT and Vypro (p=0.041, 
p=0.028) groups. This can play an important role in the results or complications of the slings.  
But et al (2005) reported the probability of the mesh migrating and thus presenting some of 
the complications mentioned above. We should recall that meshes are a foreign object in the 
body and there may be a response to these.  
Other causes may be that the kit is placed with greater tension than necessary, the quality of 
the tissue may be poor for several reasons such as: estrogen deficiency or due to poor 
dissection that leaves tissue with significant devascularization and thus with less blood 
irrigation which causes a deficiency in the fibroblast migration, in angiogenesis and 
therefore complications may arise. Surgeons who are going to place any of these devices 
should be well aware of the neurovascular anatomy of the pelvis as well as of the 
recommendations to place the chosen device.  
Letouzey et al (2011) in an experimental study in rats, used macropore and multifilament 
polypropylene mesh contaminated with Escherichia Coli, removing it after 30 days. They 
concluded that the mesh infection forms a bacterial film that acts as a lining and this may be 
associated to prosthetic erosion without observing changes in the polymer of the mesh. 
Same results have Mamy et al (2011) highlights a link between infection and shrinkage in 
the model used (rats). 
Withagen et al (2011) reported the risk factors associated to mesh exposure after insertion of 
the TVT in patients with pelvic organ prolapse; 12 months later only 294 (79%) patients were 
studied. The risk factors identified were smoking with a RR of 3.08 (IC 95% 1.09-8.72); the 
surgeons lack of experience (< than 10 years) RR 0.49 (IC 95% 0.29-0.83) and placement of a 
total Prolift RR 2.95 (IC 95% 1.24-7.01) although this is prolapse information, the TVT mesh 
was used.  
5. Complications  
We will divide complications into: intra-operative and post-operative (immediate and late).  
5.1 Intra-operative complications 
5.1.1 Bladder and urethral lesions 
Abouassaly et al (2004) analyzed surgical complications of the tension free tape (TVT) in six 
institutions; the procedures were carried out by 6 different urologists. They checked the 
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management of each complication and the patient outcomes. Of the 241 patients, 
complications during surgery were bladder perforation in 48 patients (5.8%). Andonian et al 
(2005) compared SPARC with TVT reporting a similar percentage in both groups 24% and 
23% respectively. Kristensen et al (2010) reported that out of 778 patients there was bladder 
perforation in 51 (6.6%). Lee et al (2010) reported 141 patients, with 9 patients (6.4%) having 
bladder perforation. When Novara et al (2010) in a systematic review of pubovaginal sling, 
retropubic tape (RT) and transobturator tape (TOT), made a comparison between 
procedures they reported that the TOT has less risk of bladder or vaginal perforation (OR: 
2.5 IC: 1.75-3.57; p<0.00001); but Revicky et al (2011) reported in 342 women with TVT, that 
the incidence of bladder lesion was 4.7% (16/342). Pushkay et al (2011) reported in 577 
patients a high incidence of bladder perforation in the TVT group vs. the TVO-O group 
(5.4% vs. 0.6%; p=0.001) George et al (2010) reported bladder perforation in 1.3% of the TVT 
group and none in the TOT group. Barry et al (2011) in a multicentric, randomized trial 
comparing TVT- Monarc at 3 months follow up, report a bladder lesion in 7/140 patients 
with TVT and 0/140 patients with Monarc. Rajendra et al (2011) reported 419 patients with 
stress urinary incontinence at 3 years follow up, 2 patients (0.5%) with bladder perforation. 
Latthe et al (2010) in his systematic review of 4 articles, report that bladder lesions with the 
TOT procedure have an OR 0.11 (IC 95%  0.05-0.25) and TVTO has an OR of 0.15 (IC 95% 
0.06-0.35).  
Bladder perforation during surgery due to the trocars is reported at 1.3% by George et al 
(2010) and up to 22% during the learning curve phase as described by Lebret et al (2001). 
Up to date there have been no reports of uretheral lesion during surgery.  
Alvárez-Bandrés et al (2010) reported complications with the mini-sling system (50 patients 
with TVT-secur and 105 with Miniarc), there were bladder perforations in 0.64% total in 
both groups which were resolved with conservative bladder drainage management.  
6. Bleeding 
Primicero et al (1999) reported one lesion of the external iliac vein in a patient with TVT 
which had to be repaired through laparotomy; Zilbert and Farrel (2001) reported one patient 
with laceration of the external iliac artery and a neurovascular bundle lesion of the obturator 
ramus when the TVT was applied. Kuuva and Nilssons (2002) reported in 1455 patients a 
lesion incidence of large vessels and nerves in 2 patients (0.1%). Flock et al (2004) reported in 
7 patients with TVT, blood loss quantified at 250 to 400 ml (2.1%); Abouassaly et al (2004) 
reported major bleeding of 500 ml in 16 women (2.5%) (16/421) with TVT. Kristensen et al 
(2010) in 778 patients with TVT reported hemorrhage that needed transfusion in 5 patients 
(0.6%), Barry et al (2011) observed that bleeding is minor in the group of patients with 
Monarc, 49 ml; in the TVT group it was 64 ml (p < 0.05), likewise surgical time was 14.6 min 
with Monarc and 18.5 min with TVT (p < 0.001). Rajendra et al (2011) reported that of 419 
patients with TVT-O, 3 patients (0.8%) had a blood loss over 200 ml. Dunn et al (2004) 
reported 30 cases with vascular injury including 2 fatalities.  
Brink (2000) reported one case of intestinal lesion that was repaired with a good outcome for 
the patient. Although we have minimally invasive procedures, these also pose arterial 
complications as Jung et al (2010) reported in a patient with TVT-secur who presented a 
www.intechopen.com
 
Urinary Incontinence 248 
lesion of the internal pudendal artery. The complication was resolved with embolization of 
the artery guided with angiography, the treatment was successful. Jabureck et al (2011) 
documented that retropubic access surgery has a high lesion incidence of paraurethral, 
bladder and paravesical plexus vessels and even external iliac vessels.   
7. Nerve lesion 
Kuuva and Nilsson (2002) reported a nerve lesion 0.7/1000 with the placement of TVT.  
7.1 Immediate post-surgical complications 
7.1.1 Hematomas 
Abouassaly et al (2004) reported a pelvic hematoma in 4 (1.9%) patients with TVT (4/421), 
Andonian et al (2005) reported a single case of an infected pelvic hematoma in the SPARC 
group and none in the TVT group. Pushky et al (2011) found that the formation of a 
hematoma is more frequent with TVT than with TVT-O (9.1% vs. 1.5%; p=0.001). Flock et al 
(2011) reported successful treatment of hematomas with retziusscopy in patients with TVT, 
of 685 patients, only 28 (4.1%) had a symptomatic hematoma in the Retzius space and in 
only 10 cases (1.5%) the volume exceeded 250 ml (range of 250-1000ml), the first case was 
resolved through laparotomy but the other cases were resolved successfully with a drainage 
through a retziusopy; this is a minimally invasive procedure. Latthe et al (2010) in a 
systematic review of 12 papers observed that the formation of hematomas is lower with the 
TOT procedure compared with the TVT with an OR of 0.06 (IC 95% 0.01-0.30). When 
Alvárez-Bandrés et al (2010) compared TVT –secur and Miniarc; they reported one case of 
hematoma of the obturator fossa (0.64%) in the Miniarc group, which resolved 
spontaneously. 
8. Voiding disorders 
Abouassaly et al (2004) reported urinary retention (>24 hours later) in 47 patients (19.7%). Of 
the 47 patients, retention was present in only 32 less than 48 hours later, which were 
managed with clean intermittent catheterization, the remaining 15 patients also had clean 
intermittent catheterization for several days and only one patient had catheterization for 22 
days. In order to resolve retention in 7 patients, the mesh had to be released and in 3 
patients the mesh had to be cut. Kristensen et al (2010) reported difficulty in voiding in 56% 
and 16.6% had urinary retention, 34.3% of the patients had catheterization and 8% needed 
continuous catheterization. They conclude that patients who had voiding dysfunction prior 
to surgery have an OR of 1.80 to present urinary retention post surgically. Lee et al (2010) 
reported that 10 patients with TVT surgery, (7.1%) had urinary retention after surgery; 
patients were treated with clean intermittent catheterization less than 1 week, 10 patients 
(7.1%) needed continuous catheterization and in 2 patients the TVT mesh had to be cut. 
George et al (2010) reported voiding difficulty with a follow up of 2 years; in the TVT group 
9.3% it lasted less than one week and in 2.6% it lasted more than one week. In the TOT 
group, the voiding dysfunction was 4.1% less than 1 week and 1.4% more than 1 week. 
Bladder perforation has a higher incidence in the TVT group. Revicky et al (2011) reported 
urinary retention in 9% (31/342). Sun and Tsai (2011) reported a voiding dysfunction 
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frequency of 6.8% with MONARC (5/73). Latthe et al (2010) in a systematic review of 
voiding disorder it is slightly lower in the TOT group than in the TVT-O group, but it wasn’t 
statistically significant; for TOT the OR was 0.61 (IC 95% 0.35-1.07) and for TVT-O the OR 
was 0.81 (IC 95% 0.48-1.31 
9. Infection 
Abouassaly et al (2004) reported infection of the supra pubic wound in one patient (0.4%). 
Kristensen et al (2010) reported infection of the urinary tract in 3.1%. 
Flam et al (2009) had a patient with necrotizing fasciitis after placement of the TVT-O; they 
performed extensive debridement of the affected site, a colostomy, antibiotic therapy and 8 
sessions of hyperbaric oxygen. Fig. 1 
 
Fig. 1. 65-year-old with urinary incontinence, underwent a multifilament transobturator 
sling. At 14 months follow up, she experienced severe pelvic pain and vaginal discharge. 
Clinical examination revealed hyperthermia to 400C, sling exposure at right vaginal sulcus 
and severe cellulitis in the genital-crural fold: Classification: 3C T4 S 2 and 6C T4 S3 
Lee et al(2011) in four of the five patients presented with symptom of chronic vaginal 
discharge and these patients have a chronic infection forming a sinus tract into the vagina or 
other viscus, causing symptoms years after its mesh placement. 
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10. Late complications 
10.1 De novo urgency 
Abouassaly et al (2004) reported de novo urgency in 36 patients (15%), Lleberia-Juanós et al 
(2011) determined the incidence of de novo urgency with VT (in 243 patients) and with TVT-
O (123 patients) evaluating them at 1, 6, 12 and 36 months after surgery. De novo urgency 
occurs in 13.4% of patients at 6 months, in 19.3 at 12 months and in 22.1% at 36 months. De 
novo urgency was more frequent in the TVT group than in the TVT-O group at 12 months 
(22.2% vs. 11.2%, P=0.025) and at 24 months (24.8% vs. 12.3%, P=0.033). Lee et al (2010) after 
6 years of observation reported that de novo urgency was present in 28% (30/107) and de 
novo overactive bladder with incontinence was present in 27.1% (29/107) of patients. Sun 
and Tsai (2011) reported a frequency of de novo urgency of 2.7% with MONARC (2/73). 
Sabadell et al (2011) reported that 23 patients failed to TOT and a TVT was placed in a 
second surgery; de novo urgency occurs in 5 cases (21.7%) and it is treated with oral 
anticholinergics with a good clinical response.  
11. Voiding disorders 
Rajendra et al (2011) reported after a 3 year follow up, that 11 patients with TVT-O (2.6%) 
(11/419) were readmitted since 10 patients had voiding dysfunction, in 6 patients it was 
necessary to remove or cut the tape. Reich et al (2011) reported it in 108 patients in a follow 
up period of 102 months (range of 85-124).  They did not find adverse effects of the mesh; 
90% of these patients presented urgency incontinence and were dissatisfied with the 
surgical procedure. The same group studied 478 with TVT and voiding dysfunction, 
documenting it by measuring residual volume pre and post surgery; they reported 
micturition dysfunction in the first 2 weeks in 4 patients (0.8%), 7.1% had a residual volume 
of 50-100 ml at 3 months of surgery and 2.6% had a residual urine volume of over 100 ml. 
Therefore, a total of 93% of patients did not show bladder voiding disorders after a follow 
up of 12 to 74 months, which was documented through translabial ultrasound. Alvárez-
Bandrés et al (2010) reported that the Miniarc group had urethral obstruction and thus the 
mesh had to be cut.  
12. Pain and suprapubic discomfort 
Abouassaly et al (2004) reported persisting suprapubic discomfort in 18 (7.5%) (18/241 
patients). Rajendra et al (2011) after following up 419 patients for 3 years reported persistent 
pain in 15 patients (3.6%). Ross et al (2009) reported 199 patients, 105 of these had a TVT 
inserted and 94 patients had a TVT-O; they documented in the vaginal examination that the 
mesh was palpable in 68 (80%) in the TVT-O group and in 24 (27%) of the TVT group ( RR 
0.22, CI 95% 0.13-0.37, P<.001); many women are also experiencing groin pain during 
vaginal palpation, 13 patients (15%) in the TVT-O group and 5 patients (6%) in the TVT 
group.   
Latthe et al (2010) did a systematic review reporting that groin and/or thigh pain with the 
TVT-O procedure has an OR of 8.05 (IC 95% 3.78-17.16). 
When Alvárez-Bandrés et al (2010) compared TVT-secur and Miniarc; the Miniarc group 
reported 4 (2.5%) patients with groin pain who were treated successfully with NSAID’s.  
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12.1 Mesh extrusion 
Abouassaly et al (2004) reported one patient with mesh erosion intravaginally (0.4%) 
(1/241); Andonian et al (2005) reported a single case of erosion in the SPARC group (1/41) 
and none in the TVT group (0/43). During the first year of follow up Rajendra et al (2011) 
reported vaginal erosion in 2.4 % (10/419); Ortega et al (2009) reported 1 case of 
erosion/extrusion of the mesh toward the urethra, the mesh was resected transvaginally 
with a good outcome. Wijffels et al (2009) reported 3 patients with urethral 
erosion/extrusion, treated by resection of the mesh endoscopically; Matsumura et al (2010) 
reported that after 2 years of surgery a 72 year old patient had an erosion/extrusion of the 
mesh in the urethra and a stone in the same site; management was done endoscopically with 
resection of the mesh and the stone was treated with lithotripsy with a good response.  
Latthe et al (2010) in a systematic review reported that the mesh erosion of TVT-O has an 
OR 0.77 (IC 95% 0.22-2.72), while TOT and TVT have an almost similar OR 1.11 (IC 95% 
0.54-2.28) Fig. 2  
 
Fig. 2. A 47-years-old woman underwent a transobturator tape for USI. At 5 months follow-
up, she reported vaginal discharge. Clinically she was febrile at 380C with a large sling 
extrusion as depicted. Classification: 3C T3 S1 
When Alvárez-Bandrés et al (2010) compared TVT-secur and Miniarc they reported vaginal 
erosion in 8 patients (5%); 4 patients required removal and closure of the vaginal wall, 2 
were treated with local estrogen therapy in the vagina and 2 were asymptomatic and did 
not require any treatment.   
Lo and Nusse (2010) reported a rare case of erosion over the bladder dome with formation of a 
stone 11 years after insertion of the TVT. Diagnosis was made with cystoscopy after the patient 
referred symptoms of the lower urinary tract for 5 months. A cysto-lithotripsy was performed 
observing a small filament of the mesh that was removed. A control cystoscopy was made 
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after one year showing recurrence of a stone in the same site of the previous surgery; surgery 
was performed in the office since the patient refused major surgery.  Siegel (2006) reported one 
case of urethral necrosis and a urethra-vaginal fistula in a 64 year old woman, who needed 3 
surgeries; initially TVT mesh fragments were removed and adjacent tissue needed 
debridement. A urethroplasty was performed as a second surgical procedure and in the third 
surgery a coaptation with an occlusive sling was made to repair the continence.   
E Kobashi’s (2009) reviewed the different materials and reported the rate of extrusion of 
these. Table 5.  
 
Material Fiber type Pore Size Extrusion Rate (%) 
Silicone Monofilament Macro 40-71 
TVT Monofilament Macro 2-3 
Prolapse repair Monofilament Macro Up to 26 
Obtape Monofilament Micro 5.4-16.6 
Sparc/Monarc Monofilament Macro 1.7-2.4 
Table 5. Synthetic mesh types, Characteristics and Associated Vaginal Extrusion rates.  
Miraliakbari and Tse (2011) reported the first case of ureteral erosion in a 78 year old 
woman, the erosion was located in the distal third of the ureter, and the patient was treated 
successfully.    
Rouprêt et al (2010) reported resection of the mesh via laparoscopy in 38 women with 
bladder erosion, vaginal extrusion, bladder obstruction and groin pain. The resection was 
complete with an operating time of 110 minutes (50 to 240 minute range) all patients 
reported a decrease in symptoms in a follow up period of 37.9 months (2-80 months range). 
However, the incontinence recurrence rate is 65.7% (25 patients). Laparoscopic resection of 
the TVT is safe and technically possible and solves patient’s symptoms.  
Novara et al (2010) did a systematic review of pubovaginal sling; retropubic tape (RT) and 
transobturator tape (TOT) the subjective cure rate is similar among those procedures. 
Patients who have a TOT inserted have less risk of bladder or vaginal perforation (OR: 2.5 
IC: 1.75-3.57; p<0.00001); less risk of hematoma (OR: 2.62; CI: 1.35-5.08; p=0.005) and less 
risk of urinary tract injury (OR: 1.35; CI: 1.05-1.72; p=0.02). This meta-analysis showed 
similar results between TVT-O and Monarc. The use of a retropubic tape had a higher 
objective rate than TOT, but the subjective cure is similar for both.  
Mendoca et al (2011) report two cases with late urethral erosion with transobturator 
suburethral mesh (Obtape) the first one diagnosed 1 year after the surgery and the second 
one, a very late complication, occurring 4 years after the placement of the sling. 
13. Intestinal lesion 
With an intestinal lesion, patients refer abdominal pain, peritoneal irritation and sometimes 
fecal matter leak through the incisions of the kit used (TVT) as was reported by Meschia et al 
www.intechopen.com
 
Surgical Complications with Synthetic Materials 253 
(2002); Leboeuf et al (2003) and Castillo et al (2004). Leboeuf et al (2004) did a vaginal 
hysterectomy in a 73 year old patient due to genital prolapse followed by insertion of a TVT, 
during the post-op period she presented abdominal distension, and in an axial CAT scan 
they observed bowel distention and the bowel lesion site; they did an exploratory 
laparotomy where they found perforation of the mesentery without no other lesion, the 
perforation was repaired without complications.  
Phillips et al (2009) reported a small size, thin patient with clinical signs of intestinal 
obstruction 3 years after the insertion of a TVT; she underwent an exploratory laparotomy 
where they found that the TVT mesh went through the peritoneum and was attached to the 
distal ileus; they did a resection and a primary anastomosis.   
14. Nerve lesion 
Geis and Dietl (2002) reported an ilioinguinal nerve lesion after insertion of a TVT, this due 
to the closeness of the nerve to the sites where the suprapubic incision was made. Rigaud et 
al (2010) said that pelvic or perineal pain may be a consequence of the obturator nerve or 
pudendal nerve lesion, a clinical sign that is underestimated.  
15. Sexual function 
Lau et al (2010) evaluated the impact of TVT-O insertion on sexual function in 56 women; 
they were evaluated through short questionnaires PISQ-12, UDI-16 and the IIQ7 before and 
6 months after surgery. Their conclusion was that women perceived the surgery was 
successful but there was no improvement in sexual function.  
16. Success and failure  
Jain et al (2011) did a systematic review of TVT and TOT in the treatment of Mixed Urinary 
Incontinence (MUI). The subjective cure rate in 7 prospective trials was 56.4% (IC 95% 45.7-
69.6%) in a follow up period of 34.9±22.9 months. The cure rate for stress urinary 
incontinence varied from 85% to 97% in a follow up period of 6 to 31 months. TVT and TOT 
have a similar cure in mixed urinary incontinence. Madhuvrata et al (2011) in a systematic 
review and meta-analysis of the mini-sling (SIMS) compared the retropubic procedure: TVT 
(9 studies were included) and TVT-O (7 studies were included). The objective short term 
cure rate (6-12 months) was greater in urethral sling procedures than in mini-slings (SIMS) 
with a RR 1.20 (IC 95% 1.01-1.43) and RR 1.18 (IC 95% 1.04-1.34); a second surgery was 
necessary in the SIMS group with a RR 0.15 (IC 95% 0.05-0.42). Novara et al (2010) in a 
systematic review and meta-analysis of 39 papers reported that patients who had a sub-
urethral mesh inserted the objective cure rate had an OR: 0.38 (IC95% 0.25-0.57; p=<0.0001) 
compared to the patients who had a Burch colpo-suspension procedure, although they had a 
high bladder perforation risk with an OR of 4.94 (IC 95% 2.09-11.68; p= 0.00003). Patil (2011) 
in a total of 12977 surgeries performed in 68 centers in the United Kingdom, 313 patients 
(2.4%) failed to sub-urethral slings. Chen et al (2011) in 30 patients followed up 1 year, who 
had a TVT-secur inserted, the success rate decreased significantly from 83.3% one month 
after surgery to 60.0% one year after the procedure.  
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17. Risk factors for surgical failure 
Abdel-Fattah et al (2010) did a randomized report of 341 patients who had an outside-in 
transobturator (TOT-ARIS) and an inside-out (TVT-O). The risk factors for failure in the 
insertion of these meshes are: prior incontinence surgery (OR 1.41; 95% CI 1.18, 1.91; P = 
0.029), preoperative urgency urinary incontinence (OR 1.78; 95% CI 1.21, 3.91, P = 0.048) 
during the first year of follow up of these surgeries.  
Revicky et al (2011) evaluated the following risk factors to predict failure of the procedure: 
body mass index (BMI), age, type of analgesia, concomitant prolapse repair or prior surgery 
and obesity. These factors were not related to bladder injury or to urinary retention. Liu et al 
(2011) reported that obesity was not a risk factor for surgical failure just like Revicky 
reported in his review.  
When Pushkar et al (2011) evaluated risk factors like age, body mass index and parity; there 
was no correlation with the complications of TVT and TVT-O. 
18. Diagnosis 
All patients who have had any of the anti-incontinence kits available in the market placed 
through the following procedures: retropubic, transobturator, outside-in or inside-out, or 
any minimally invasive kit, should be followed up long term since complications have been 
observed up to 11 years after insertion.   
For intra-operative complications it is necessary to observe the patient’s vitals: heart rate, 
blood pressure, oxygen saturation, state of awareness, so that if a disturbance is observed in 
any of these parameters, any necessary additional tests can be performed; like clinical labs to 
diagnose a vascular complication. A cystoscopy should be performed to assess the entire 
bladder with proper distention (250 cc minimum of physiologic solution) and with the 
proper instrument like a 700 lens cystoscope in order to check the bladder dome and lateral 
bladder walls; and for the urethra a 00 or 300 lens. In the event of doubt we can use 
methylene blue or indigo carmine to identify any damage that may be overlooked. 
Hematomas are identified according to the amount or size of the hematoma, it can go from 
mild pain, ecchimosis or hemorrhage through the puncture sites; this can be confirmed with 
imaging tests (ultrasound, axial CAT scan, MRI) depending on the patient’s clinical status.   
For post-operative complications: signs and symptoms of a patient who refers voiding 
disorders, residual urine should be measured using a clean bladder catheter or with 
translabial or suprapubic ultrasound in order to measure urine. De novo urgency can be 
documented by asking the patient directly and with a multichannel Urodynamic or Video-
Urodynamic test, depending on the discomfort reported by the patient. During the patient’s 
visit to the office, the vagina and urethra must be checked to discard any extrusion 
complications. A cystoscopy, a urethroscopy or an additional test must be performed 
depending on the symptoms reported by the patient. If the patient shows any irritation 
symptoms in the lower urinary tract or in the bowel, hematuria, dispareunia, discomfort 
reported by the spouse, voiding disorders, pain, recurring infections, palpation of the mesh 
or recurring urinary incontinence, the integrity of the urinary tract and adjacent organs must 
be documented. If a patient has an intestinal injury, they will refer abdominal pain, signs of 
peritoneal irritation and sometimes leak of fecal matter through the incision of the kit used.  
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Rigaud et al (2010) said that when the patient refers perineal pain or chronic pelvic pain, 
immediately or shortly after insertion of a TVT or TOT Kit, this is probably associated 
directly or indirectly to a nerve injury (obturator nerve or pudendal nerve); diagnosis is 
made with the history that pain started after insertion of the kit and it can be confirmed with 
infiltration of local anesthesia through the mesh. This complication may be underestimated.  
18.1 Treatment 
Treatment of complications with these kits is still not standardized and it is something we 
will have to work on. When complications are severe, a multidisciplinary team is necessary 
to provide the best treatment and obtain favorable results for the patient. 
18.2 Treatment of intra-operative complications 
Complications due to punctures are caused by the passage of the kit’s trocar, it can injure 
the urethra or the bladder, therefore, during the retropubic inside-out or outside-in 
procedure, a cystoscopy using a 700 lens should be performed in order to see the dome of the 
bladder and lateral walls; and a 00 to 300 lens to properly evaluate the urethra; so that under 
this direct view we can see whether the trocar is inside the bladder or urethra before placing 
the mesh. In the event the trocar punctures the bladder or urethra, it can be removed and 
inserted again. If there is no evidence of puncture to the urethra and/or bladder, it is now 
possible to place the mesh and a cystoscopy should be repeated. In the event of bladder 
injury, the size of the puncture should be measured and if small, a continuous drainage 
should be left with a Foley catheter for 48 to 72 hours. When the bladder damage is larger, a 
primary repair is necessary with 2 layers of absorbing suture (vicryl) and a continuous 
drainage using a Foley Catheter for 5 to 7 days should also be placed.  
Flock et al (2011) reported 7 patients with TVT who had hemorrhage of 250ml to 400 ml that 
was managed with cautherization, compression or tamponade. Zorn et al (2005) recommend 
an exploratory laparotomy to repair the vascular damage and for proper hemostasis, or an 
embolization in patients who present massive bleeding after placement of the TVT; if we 
have this technique it provides good results.   
Hubka et al (2010) recommend the patient be placed in a proper position in order to stay 
away from the obturator neurovascular bundle, this way, the success rate increases and the 
number of neurovascular damage decrease.  
18.3 Treatment of post-operative complications 
Abouassaly et al (2004) recommend in patients with voiding dysfunctions, the use of clean 
intermittent catheterization and if it has to be for a longer period of time, the mesh must be 
released, and in patients who continue with voiding disorders the mesh must be cut.  
Abouassaly et al (2004) reported that when an infectious process arises, a culture must be 
performed and antibiotics should be prescribed depending on the sensitivity obtained; and 
as reported by Flam et al (2009) hyperbaric oxygen can be used to improve oxygenation of 
the tissue involved with excellent results. Abouassaly et al (2004) recommend for 
intravaginal mesh erosion, partial resection of the meshes and repair of the vaginal 
epithelium if the patient refers symptoms if not, she can just be observed as reported by 
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Alvárez-Bandrés et al (2010). Giri et al (2007) recommend a primary closure of the vaginal 
mucosa with a single line of a polyglactine 910, 2/0 suture avoiding inversion of the 
mucosa, when there is extrusion of the TVT mesh toward the vagina.  
Rouprêt et al (2010) reported surgical resection of the mesh through laparoscopy, in 38 
women with complications like: bladder erosion, vaginal extrusion, bladder obstruction and 
groin pain. Resection was complete in all patients through laparoscopy; with an operating 
time of 110 minutes (range of 50 to 240 minutes) all patients reported a decrease in 
symptoms in a follow up period of 37.9 months (range 2-80 months). However, the 
recurrence rate of incontinence was 65.7% (25 patients). Laparoscopic resection of the TVT is 
safe and technically possible and solves patient’s symptoms if we have the necessary 
instruments as well as trained personnel since it is a minimally invasive treatment 
alternative. In patients with de novo urgency, the use of anticholinergics is necessary to 
improve the patient’s quality of life and in patients who report pelvic or perineal pain we 
can prescribe NSAID’s.  
When there is mesh extrusion and there is no satisfactory response to primary management 
such as the use of antibiotics or application of local estrogen in the organ extruded; the 
appropriate management is to remove the mesh. Fig 3. Removal of the mesh has been 
performed vaginally, via the urethra or the ureter through cystoscopy or laparoscopy with a 
good success rate and it is a minimally invasive procedure.  
 
Fig. 3. The appropriated  management is to remove the mesh when there is no satisfactory 
response to primary management. 
Lo and Nusse (2010) recommend that in patients who have had a TVT or any other kit 
inserted to treat urinary incontinence and who show irritation symptoms of the lower 
urinary tract, a cystoscopy must be done to discard the presence of the mesh in the vagina, 
the urethra or in any other organ. If an intestinal injury is suspected, additional imaging test 
should be performed to document the injury and an exploratory laparotomy will be 
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necessary to repair the injury, with an intestinal resection and/or colostomy depending on 
the lesion found.  
Rigaud et al (2010) said that for the treatment of pelvic or perineal pain we can infiltrate 
local anesthesia throughout the mesh or in the nerves involved, thus achieving temporary 
clinical improvement. However, although there was improvement in 2 of their 3 patients, 
the mesh had to be removed.  
Mendoca et al(2011) describe a minimally invasive trans-urethral approach for the urethral 
erosion under local anaesthesia. They present some “tricks of the trade” on retrieving the 
tape trans-urethrally while maximizing the length of tape removed. 
Khong and Lam (2011) in nine patients with synthetic mesh erosion when failed to respond 
to conservative measures were managed surgically with Surgisis. The size erosion ranged 
from 1 to 4 cm in diameter. The Surgisis may prove to be a useful option in the treatment of 
large vaginal mesh defects. 
19. Conclusion  
Whenever a surgical procedure involving the use of a mesh for urinary incontinence (any 
sort of mesh found in the market), the patient and her family must be informed about risks 
and complications. It is also important to have an informed consent for the patient stating 
the incidence of each of the complications pertaining to the specific kit used. Surgeons 
should follow patients at long term, since many complications occur after a long time, and 
they should be prepared to act quickly and effectively to solve the complication that has 
arisen. The use of new technology has improved the success rate of the surgical procedures 
for urinary incontinence, but clinically and legally, surgeons are the ones that should 
determine the use of these new devices and not the representatives of the commercial 
houses. We suggest that all suburethral slings are not created equal and that clinical 
adoption of new technology should follow clinical trials demonstrating efficacy, safety and 
long-term outcomes. 
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